HAMILTON ENTERPRISES INC

What HAMILTON ENTERPRISES INC does

QuinTron Instrument Company, Inc., operating under the legal entity Hamilton Enterprises Inc., is a privately held medical device manufacturer headquartered and manufacturing in New Berlin, Wisconsin. The company specializes in breath testing systems for digestive disorder diagnostics, with its core product — the BreathTracker analyzer — using solid-state sensors to measure trace hydrogen and methane concentrations correlated with conditions such as Small Intestinal Bacterial Overgrowth (SIBO), Intestinal Methanogen Overgrowth (IMO), and carbohydrate malabsorption. The product portfolio includes three patented collection devices: the EasySampler (closed-system at-home kit with up to 14-day sample stability), the AlveoSampler (economical disposable single-patient in-office system), and the GaSampler (in-office consistent-sample disposable system for adult and pediatric use).

The business operates across three go-to-market motions: direct enterprise sales of analyzers to hospitals, clinics, and laboratories; a channel model in which healthcare professionals stock kits and patients ship samples to analysis partners for processing with 48-hour turnaround; and direct-to-consumer e-commerce via the company's online store. Revenue is generated through hardware sales of analyzers and collection kits, plus a managed-services component via the analysis partner network. QuinTron holds FDA registration (#2124914), ISO 13485:2016 certification (MDSAP 671378 and FM 671377), and its methodology is cited in over 100 research articles and consensus papers.

The company serves a globally distributed customer base described as "thousands of hospitals, clinics, and laboratories worldwide," spanning gastroenterology, naturopathic medicine, and integrative medicine practice segments. Pricing is quote-based and not publicly disclosed, with breath tests reimbursable under CPT 91065. With approximately 35 employees and no disclosed funding rounds, the company operates as a focused, self-funded specialty medical device business positioned as a low-cost, non-invasive first-line diagnostic alternative to colonoscopy and endoscopy.

Name

HAMILTON ENTERPRISES INC

Legal name

QuinTron Instrument Company, Inc.

Website

https://quintron-usa.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

QuinTron Instrument Company is a privately held medical device manufacturer producing solid-state breath analyzers and patented collection kits for diagnosing digestive disorders like SIBO and IMO. Serving thousands of hospitals, clinics, and laboratories worldwide, the company operates FDA-registered, ISO 13485-certified manufacturing from Wisconsin.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

SIC

Laboratory Analytical Instruments (3826)

akta.pro primary industry

Pulmonary Function Testing (PFT) & Spirometry Equipment (HLAHAGAH)

akta.pro secondary industry

Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry) (HLAHACAD)

Keywords

• Breath testing equipment
• Medical device manufacturing
• Diagnostic analyzers
• Digestive disorder diagnostics
• SIBO breath testing

Headquarters

HQ city

New Berlin

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Breath Analyzer Hardware Sales: Sale of QuinTron BreathTracker breath analyzers to healthcare practitioners for immediate in-office breath sample analysis.
2. Breath Testing Kits: Sale of breath collection kits including EasySampler (for patient or physician purchase), AlveoSampler (physician purchase only), and GaSampler (in-office collection). Kits enable at-home or in-office sample collection for analysis.
3. Analysis Services via Partners: Breath samples collected via kits are sent to analysis partners for processing, with results typically available within 48 hours of receipt.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

QuinTron designs, manufactures, and sells breath testing analyzers and patented disposable breath collection kits used by healthcare practitioners and patients to measure hydrogen and methane concentrations for diagnosing digestive disorders such as SIBO and carbohydrate malabsorption. Revenue is driven by hardware sales of the BreathTracker analyzer and consumable collection kits (EasySampler, AlveoSampler, GaSampler), with a complementary channel of analysis services delivered through partner laboratories.

Product overview

QuinTron Instrument Company offers a comprehensive breath testing solution portfolio for diagnosing digestive disorders. The core product is the BreathTracker analyzer, which measures hydrogen and methane concentrations using solid-state sensor technology. The system is complemented by three breath collection kit options: the EasySampler for patient self-collection at home (samples stable up to 14 days), the AlveoSampler for economical in-office physician-directed collection, and the GaSampler as the company's most recognized in-office collection system. Healthcare providers can purchase analyzers for immediate in-office testing, request supply kits for their practice, or refer patients to QuinTron's direct-to-patient online store. The company also partners with analysis labs that provide results within 48 hours of sample receipt.

Differentiator

Problem solved

Functional benefit

Products and services

• BreathTracker A breath testing analyzer that measures trace hydrogen and methane concentrations using solid-state sensor technology. Sold to healthcare practitioners for immediate in-office analysis of patient breath samples to support diagnosis of digestive disorders such as SIBO, IMO, and carbohydrate malabsorption.
• EasySampler A patented closed-system breath collection device that allows patients to collect breath samples at home without supervision. Samples remain stable for up to 14 days, supporting remote testing. Available for direct patient purchase via QuinTron's online store or for physician distribution.
• AlveoSampler A disposable, single-patient alveolar air collection system designed for economical on-site breath sample collection at clinics. Samples are collected in a special syringe for immediate analysis on a QuinTron breath analyzer. Physician purchase only.
• GaSampler A disposable, single-patient in-office breath collection system that provides consistent sample collection for adults and pediatrics. Samples remain stable in the collection bag for up to 6 hours. Physician purchase only.

Quantifiable outcome

• Samples remain stable for up to 14 days
• +2 more outcomes

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Breath Analysis PartnerscoreStrategic or Co-development PartnerNetwork of breath analysis partners who process patient samples collected via QuinTron kits. When patients ship samples using prepaid labels in their test kits, analysis partners perform the analysis and provide results within 48 hours. This enables the patient-direct and healthcare provider kit distribution models.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• Aerodiagnostics: Aerodiagnostics is an emerging provider of SIBO and small intestine-focused breath testing services. It overlaps with QuinTron's at-home kit and partner-analysis model but with a narrower provider base, making it a comparable but smaller-scale alternative.
• BioGaia: BioGaia focuses on probiotic and gut health solutions, including products and diagnostics related to digestive wellness. While not a direct breath-test competitor, it operates in the same SIBO/gut-health ecosystem that drives demand for QuinTron's testing products.
• Metabolon: Metabolon provides metabolomics-based diagnostics, including GI and microbiome-related testing, that could compete with breath testing as a first-line digestive disorder diagnostic. It represents an emerging technology approach adjacent to QuinTron's breath analysis methodology.

Direct peers

• Commonwealth Diagnostics International (CDI): CDI offers SIBO and IMO breath testing services and collection kits, including a direct-to-patient and provider-distributed model. It competes head-to-head with QuinTron's at-home kit channel and partner-analysis workflow for SIBO diagnostics.
• Genova Diagnostics: Genova Diagnostics is a clinical laboratory that performs SIBO breath testing using third-party collection devices, competing with QuinTron's analysis-partner network. It also offers broader GI and microbiome diagnostics, making it both a peer lab and a potential analysis partner.
• FAN GmbH (Fischer Analysen Instrumente): FAN GmbH produces breath test devices and collection systems specifically for SIBO, lactose intolerance, and H. pylori diagnostics in Europe. It is a direct competitor to QuinTron's BreathTracker and EasySampler products in the gastroenterology breath-testing market.
• Bedfont Scientific: Bedfont Scientific manufactures breath analysis equipment (e.g., GastroCH4ECK, Smokerlyzer) used for gastroenterology and smoking cessation diagnostics. It directly competes with QuinTron in hydrogen/methane breath testing devices and collection accessories for clinical use.

Broad incumbents

• Medtronic: Medtronic is a broad medical device incumbent with gastroenterology and diagnostic offerings (e.g., Bravo pH, PillCam). It could expand into non-invasive breath-based diagnostics, posing long-term competitive pressure on niche players like QuinTron.
• Cardinal Health: Cardinal Health distributes medical devices and laboratory products globally, including diagnostic instruments for clinical settings. It serves as both a potential distribution channel and a broad incumbent whose portfolio could overlap with QuinTron's analyzer and kit business.
• Hologic: Hologic is a diagnostics incumbent with strong women's health and gastrointestinal testing franchises. Its scale and commercial reach in clinical diagnostics could enable it to enter or acquire into the SIBO/breath testing category where QuinTron leads.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/quintroninstrumentcompany
• LinkedInlinkedin.com/company/hamilton-enterprises-inc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HAMILTON ENTERPRISES INC